| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 840 | $80 | $67.8K |
| J0897 | Injection, denosumab, 1 mg | 3,060 | $20 | $55.1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 80 | $130 | $9.7K |
| 99309 | The provider sees a patient for a subsequent nursing facility care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or the provider… | 110 | $70 | $7.7K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 90 | $70 | $6.6K |
| 99308 | The provider sees a patient for a subsequent nursing facility care visit involving evaluation and management (E/M). The visit involves a low level of medical decision making and/or the provider… | 120 | $50 | $6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 120 | $50 | $5.8K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 40 | $130 | $5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 70 | $60 | $4.3K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 490 | $10 | $3.9K |